CURE Pharmaceutical Attains Access to High Quality Hemp CBD Since Partnering with Fytiko Farms

Vertically-integrated drug delivery and development firm, CURE Pharmaceutical reported on Wednesday, August 21, 2019 that it has signed a deal with hemp cultivation firm, Fytiko Farms.

This partnership is projected to help the former expand its supply chain, as the latter will be tasked with providing them with high-quality, organic hemp material. With its uses, CURE Pharmaceutical will be able to better its proprietary Oral Thin Film (OTF) delivery system called CUREfilm®.

With CUREfilm®, the goal is to ensure that the delivery of drugs is optimized for patients. This is not just a matter of augmenting bioavailability, but also solubility and masking poor medicinal taste, all of which combined ensures full potential of drugs by hopefully reducing dose frequency and side effects.

CEO of Fytiko Farms, Joe Dan Rogers expressed that joining forces with a firm like CURE is surely give a boost to his firm, highlighting that it will help “to expand into more markets and grow our production capabilities.” Providing CURE an adequate hemp source implies that Fytiko can up their momentum as growers.

CEO of CURE Pharmaceutical, Rob Davidson also commented on the partnership, adding that the provided, organic hemp source will “put CURE in a strategic position to further deliver on our mission to bring the best products to our customers.”

With growers in check, CURE will now move forward in establishing sound relationships with vendors who will help in leveraging their extraction patents.